Credit Agricole’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $9.21M | Sell |
324,710
-17,962
| -5% | -$509K | 0.03% | 338 |
|
2024
Q4 | $14.2M | Buy |
342,672
+159,589
| +87% | +$6.64M | 0.04% | 269 |
|
2024
Q3 | $12.2M | Buy |
183,083
+62,358
| +52% | +$4.17M | 0.05% | 211 |
|
2024
Q2 | $14.3M | Buy |
120,725
+48,084
| +66% | +$5.71M | 0.08% | 165 |
|
2024
Q1 | $7.41M | Sell |
72,641
-159,565
| -69% | -$16.3M | 0.08% | 145 |
|
2023
Q4 | $23.1M | Buy |
232,206
+39,103
| +20% | +$3.89M | 0.26% | 35 |
|
2023
Q3 | $19.9M | Buy |
193,103
+20,869
| +12% | +$2.16M | 0.32% | 32 |
|
2023
Q2 | $20.9M | Buy |
172,234
+54,113
| +46% | +$6.57M | 0.38% | 29 |
|
2023
Q1 | $18.1M | Buy |
118,121
+14,827
| +14% | +$2.28M | 0.37% | 24 |
|
2022
Q4 | $18.6M | Sell |
103,294
-4,634
| -4% | -$832K | 0.38% | 25 |
|
2022
Q3 | $12.8M | Sell |
107,928
-1,646
| -2% | -$195K | 0.24% | 36 |
|
2022
Q2 | $15.7M | Buy |
109,574
+14,755
| +16% | +$2.11M | 0.38% | 34 |
|
2022
Q1 | $16.3M | Buy |
94,819
+55,742
| +143% | +$9.6M | 0.29% | 35 |
|
2021
Q4 | $9.93M | Buy |
39,077
+21,196
| +119% | +$5.38M | 0.16% | 62 |
|
2021
Q3 | $6.88M | Buy |
17,881
+4,982
| +39% | +$1.92M | 0.13% | 78 |
|
2021
Q2 | $3.03M | Sell |
12,899
-6,591
| -34% | -$1.55M | 0.06% | 150 |
|
2021
Q1 | $2.55M | Buy |
19,490
+19,190
| +6,397% | +$2.51M | 0.07% | 146 |
|
2020
Q4 | $31K | Sell |
300
-4,500
| -94% | -$465K | ﹤0.01% | 387 |
|
2020
Q3 | $340K | Buy |
+4,800
| New | +$340K | 0.02% | 208 |
|
2020
Q2 | – | Sell |
-4,735
| Closed | -$142K | – | 465 |
|
2020
Q1 | $142K | Buy |
+4,735
| New | +$142K | 0.01% | 239 |
|